Kimia Therapeutics Raises $55 Million Series A
December 19, 2023 08:30 ET
|
Kimia Therapeutics, Inc.
– Fundraise led by The Column Group and Dimension – – Kimia is advancing its ATLAS platform that combines high-throughput chemistry with chemical biology, genome editing and machine learning to...
Carmot Therapeutics Launches Spin-Off, Kimia Therapeutics, to Focus on Metabolic Disease
January 05, 2023 08:55 ET
|
Carmot Therapeutics
– Spin-off of technology platform to newly-formed Kimia Therapeutics intended to maximize the full potential of Carmot’s metabolic portfolio while enabling Kimia to pursue a broad range of...